Fulcrum Therapeutics (FULC) Change in Receivables (2020 - 2025)
Fulcrum Therapeutics (FULC) has 6 years of Change in Receivables data on record, last reported at -$979000.0 in Q2 2025.
- On a quarterly basis, Change in Receivables fell 141.96% to -$979000.0 in Q2 2025 year-over-year; TTM through Mar 2026 was -$979000.0, a 200.0% decrease, with the full-year FY2025 number at -$2.1 million, down 234.45% from a year prior.
- Change in Receivables reached -$979000.0 in Q2 2025 per FULC's latest filing, up from -$1.1 million in the prior quarter.
- Over the last five years, Change in Receivables for FULC hit a ceiling of $2.6 million in Q3 2021 and a floor of -$2.8 million in Q4 2022.
- A 5-year average of -$124882.4 and a median of -$130000.0 in 2023 define the central range for Change in Receivables.
- Peak YoY movement for Change in Receivables: tumbled 9083.87% in 2022, then soared 1840.79% in 2024.
- Tracing FULC's Change in Receivables over 5 years: stood at -$31000.0 in 2021, then crashed by 9083.87% to -$2.8 million in 2022, then soared by 98.49% to -$43000.0 in 2023, then plummeted by 3527.91% to -$1.6 million in 2024, then soared by 37.24% to -$979000.0 in 2025.
- Business Quant data shows Change in Receivables for FULC at -$979000.0 in Q2 2025, -$1.1 million in Q1 2025, and -$1.6 million in Q4 2024.